chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia
Clinical narrative: Muscle aches; cannot drive for long and cannot hold objects for longer time as it starts hurting from the elbow all the way down; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Muscle aches) and ARTHRALGIA (cannot drive for long and cannot hold objects for longer time as it starts hurting from the elbow all the way down) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. C04M202 and 037K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (Muscle aches) and ARTHRALGIA (cannot drive for long and cannot hold objects for longer time as it starts hurting from the elbow all the way down). The patient was treated with NAPROXEN SODIUM (ALEVE) at a dose of once in a while. At the time of the report, MYALGIA (Muscle aches) and ARTHRALGIA (cannot drive for long and cannot hold objects for longer time as it starts hurting from the elbow all the way down) had not resolved. Not Provided          Concomitant medications were reported as Blood thinners, Cholesterol and Blood pressure. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable. . Upon follow-up, the patient said her muscle aches still on and off and she used Band-aid on right elbow which seemed to help little bit, but it's still ongoing.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Reporter's email was added. Events outcome were updated from unknown to not recovered. Treatment medication added.
Sex: U
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Developed COVID19 symptoms; This spontaneous case was reported by a pharmacist and describes the occurrence of COVID-19 (Developed COVID19 symptoms) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced COVID-19 (Developed COVID19 symptoms). On 22-Mar-2021, COVID-19 (Developed COVID19 symptoms) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Mar-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered COVID-19 (Developed COVID19 symptoms) to be not applicable.    Concomitant medications was not provided.  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Peripheral coldness
Clinical narrative: muscle aches; extremities cold; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (muscle aches) and PERIPHERAL COLDNESS (extremities cold) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (muscle aches) and PERIPHERAL COLDNESS (extremities cold). At the time of the report, MYALGIA (muscle aches) and PERIPHERAL COLDNESS (extremities cold) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.  No treatment medications provided by the reporter.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Chills, Cough, Dyspnoea, Fatigue
Clinical narrative: chest pain; heavy breathing; dry cough; fever; headache; fatigue; chills; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (chest pain), DYSPNOEA (heavy breathing), COUGH (dry cough), PYREXIA (fever) and HEADACHE (headache) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for an unknown indication. The occurrence of additional non-serious events is detailed below.     No medical history reported.     On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (chest pain), DYSPNOEA (heavy breathing), COUGH (dry cough), PYREXIA (fever), HEADACHE (headache), FATIGUE (fatigue) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, CHEST PAIN (chest pain), DYSPNOEA (heavy breathing), COUGH (dry cough), PYREXIA (fever), HEADACHE (headache), FATIGUE (fatigue) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment medication included Tylenol.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: chest pain; heavy breathing; dry cough; fever; headache; fatigue; chills; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (chest pain), DYSPNOEA (heavy breathing), COUGH (dry cough), PYREXIA (fever) and HEADACHE (headache) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for an unknown indication. The occurrence of additional non-serious events is detailed below.     No medical history reported.     On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (chest pain), DYSPNOEA (heavy breathing), COUGH (dry cough), PYREXIA (fever), HEADACHE (headache), FATIGUE (fatigue) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, CHEST PAIN (chest pain), DYSPNOEA (heavy breathing), COUGH (dry cough), PYREXIA (fever), HEADACHE (headache), FATIGUE (fatigue) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment medication included Tylenol.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Feeling jittery, SARS-CoV-2 test
Clinical narrative: Jittery; Difficulty breathing; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FEELING JITTERY (Jittery) and DYSPNOEA (Difficulty breathing) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     Concomitant products included ALBUTEROL SULFATE, ASCORBIC ACID, ATORVASTATIN, CARVEDILOL, ENALAPRIL, FOLIC ACID, HYDROXYCHLOROQUINE SULFATE (HYDROXYCHLOROQUINE SULPHATE) and SULFASALAZINE for an unknown indication.   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2. On an unknown date, the patient experienced FEELING JITTERY (Jittery) and DYSPNOEA (Difficulty breathing). The patient was treated with REMDESIVIR at a dose of UNK dosage form. At the time of the report, FEELING JITTERY (Jittery) and DYSPNOEA (Difficulty breathing) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Mar-2021, SARS-CoV-2 test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Other treatment medication included antibiotic, blood thinners   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: TCR added
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Intentional product use issue, Muscle spasms
Clinical narrative: Difficulty breathing; Muscle spasms; Decided not to get the second dose of Moderna vaccine due to her reaction; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Difficulty breathing), MUSCLE SPASMS (Muscle spasms) and INTENTIONAL PRODUCT USE ISSUE (Decided not to get the second dose of Moderna vaccine due to her reaction) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Difficulty breathing), MUSCLE SPASMS (Muscle spasms) and INTENTIONAL PRODUCT USE ISSUE (Decided not to get the second dose of Moderna vaccine due to her reaction). At the time of the report, DYSPNOEA (Difficulty breathing), MUSCLE SPASMS (Muscle spasms) and INTENTIONAL PRODUCT USE ISSUE (Decided not to get the second dose of Moderna vaccine due to her reaction) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.       No concomitant medications reported by investigator  No treatment medications provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Follow-up received on 10-May-2021, updated the outcome of the events (difficulty breathing and muscle spasms) and patient stated that she want to withdrawn her 2nd dose due to her reaction coded as event intentional deviation of dosage regimen.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Vaccination site pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose was taken on 30Jan2021,second dose of the vaccine on 12March2021) and VACCINATION SITE PAIN (soreness in the arm) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A and 0010M20A) for COVID-19 vaccination. Concurrent medical conditions included Diabetes, Hypertension and COPD. On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Jan-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose was taken on 30Jan2021,second dose of the vaccine on 12March2021). On 12-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (soreness in the arm). On 12-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose was taken on 30Jan2021,second dose of the vaccine on 12March2021) had resolved. At the time of the report, VACCINATION SITE PAIN (soreness in the arm) had resolved. Concomitant products include medication for diabetes, hypertension, and COPD. Treatment information was not provided. Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: Reporter contact information was updated, NNI.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Cough, Fatigue, Headache, Myalgia
Clinical narrative: dry cough; low grade fever 98.9 to 99.9; achy joints; achy muscles; headache; couple days of fatigue; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), COUGH (dry cough), PYREXIA (low grade fever 98.9 to 99.9), ARTHRALGIA (achy joints) and MYALGIA (achy muscles) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LEVOTHYROXINE for an unknown indication.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On an unknown date, the patient experienced COUGH (dry cough), PYREXIA (low grade fever 98.9 to 99.9), ARTHRALGIA (achy joints), MYALGIA (achy muscles), HEADACHE (headache) and FATIGUE (couple days of fatigue). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm), PYREXIA (low grade fever 98.9 to 99.9), ARTHRALGIA (achy joints), MYALGIA (achy muscles), HEADACHE (headache) and FATIGUE (couple days of fatigue) outcome was unknown and COUGH (dry cough) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.     The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the mRNA-1273 in response to the events was not applicable.   This case was linked to MOD-2021-054686 (Patient Link).
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: dry cough; low grade fever 98.9 to 99.9; achy joints; achy muscles; headache; couple days of fatigue; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), COUGH (dry cough), PYREXIA (low grade fever 98.9 to 99.9), ARTHRALGIA (achy joints) and MYALGIA (achy muscles) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LEVOTHYROXINE for an unknown indication.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On an unknown date, the patient experienced COUGH (dry cough), PYREXIA (low grade fever 98.9 to 99.9), ARTHRALGIA (achy joints), MYALGIA (achy muscles), HEADACHE (headache) and FATIGUE (couple days of fatigue). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm), PYREXIA (low grade fever 98.9 to 99.9), ARTHRALGIA (achy joints), MYALGIA (achy muscles), HEADACHE (headache) and FATIGUE (couple days of fatigue) outcome was unknown and COUGH (dry cough) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.     The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the mRNA-1273 in response to the events was not applicable.   This case was linked to MOD-2021-054686 (Patient Link).
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Dry mouth, Hyperhidrosis, Mobility decreased
Clinical narrative: rash in both cheeks; hot sweats at night; Can hardly move my neck; extremely thirst at night; mouth feels very dry; aching all over; low grade fevers in the evening; Chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (hot sweats at night), MOBILITY DECREASED (Can hardly move my neck), THIRST (extremely thirst at night), DRY MOUTH (mouth feels very dry) and MYALGIA (aching all over) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Thrombocythemia (central thrombocythemia). Concomitant products included INTERFERON for Thrombocythemia.   On 10-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Feb-2021, the patient experienced MYALGIA (aching all over), PYREXIA (low grade fevers in the evening), CHILLS (Chills) and PYREXIA (fever). On 09-Feb-2021, the patient experienced HYPERHIDROSIS (hot sweats at night), MOBILITY DECREASED (Can hardly move my neck), THIRST (extremely thirst at night) and DRY MOUTH (mouth feels very dry). On 22-Mar-2021, the patient experienced RASH (rash in both cheeks). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. On 09-Feb-2021, MYALGIA (aching all over), CHILLS (Chills) and PYREXIA (fever) had resolved. At the time of the report, HYPERHIDROSIS (hot sweats at night), MOBILITY DECREASED (Can hardly move my neck), THIRST (extremely thirst at night), DRY MOUTH (mouth feels very dry), RASH (rash in both cheeks) and PYREXIA (low grade fevers in the evening) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Feb-2021, Body temperature: 101 (Inconclusive) 101 degrees Fahrenheit fever.         Action taken with mRNA-1273 in response to the event was not applicable.  Patient received treatment of Muscle Relaxant.   Most recent FOLLOW-UP information incorporated above includes: On 02-Jul-2021: TCR updated email address, NNI
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia, Rash, Thirst
Clinical narrative: rash in both cheeks; hot sweats at night; Can hardly move my neck; extremely thirst at night; mouth feels very dry; aching all over; low grade fevers in the evening; Chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (hot sweats at night), MOBILITY DECREASED (Can hardly move my neck), THIRST (extremely thirst at night), DRY MOUTH (mouth feels very dry) and MYALGIA (aching all over) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Thrombocythemia (central thrombocythemia). Concomitant products included INTERFERON for Thrombocythemia.   On 10-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Feb-2021, the patient experienced MYALGIA (aching all over), PYREXIA (low grade fevers in the evening), CHILLS (Chills) and PYREXIA (fever). On 09-Feb-2021, the patient experienced HYPERHIDROSIS (hot sweats at night), MOBILITY DECREASED (Can hardly move my neck), THIRST (extremely thirst at night) and DRY MOUTH (mouth feels very dry). On 22-Mar-2021, the patient experienced RASH (rash in both cheeks). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. On 09-Feb-2021, MYALGIA (aching all over), CHILLS (Chills) and PYREXIA (fever) had resolved. At the time of the report, HYPERHIDROSIS (hot sweats at night), MOBILITY DECREASED (Can hardly move my neck), THIRST (extremely thirst at night), DRY MOUTH (mouth feels very dry), RASH (rash in both cheeks) and PYREXIA (low grade fevers in the evening) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Feb-2021, Body temperature: 101 (Inconclusive) 101 degrees Fahrenheit fever.         Action taken with mRNA-1273 in response to the event was not applicable.  Patient received treatment of Muscle Relaxant.   Most recent FOLLOW-UP information incorporated above includes: On 02-Jul-2021: TCR updated email address, NNI
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Limb discomfort, Rash pruritic, Tachycardia
Clinical narrative: Rash on the wrist and on both arms  bumps that are itchy; faster heartbeat that usual; Soreness on the shoulder; Soreness underneath the arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (Rash on the wrist and on both arms  bumps that are itchy), TACHYCARDIA (faster heartbeat that usual), ARTHRALGIA (Soreness on the shoulder) and LIMB DISCOMFORT (Soreness underneath the arm) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced RASH PRURITIC (Rash on the wrist and on both arms  bumps that are itchy), TACHYCARDIA (faster heartbeat that usual), ARTHRALGIA (Soreness on the shoulder) and LIMB DISCOMFORT (Soreness underneath the arm). At the time of the report, RASH PRURITIC (Rash on the wrist and on both arms  bumps that are itchy), TACHYCARDIA (faster heartbeat that usual), ARTHRALGIA (Soreness on the shoulder) and LIMB DISCOMFORT (Soreness underneath the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concominant medications were not reported.  Treatment information was not provided.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: chills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M2CA) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHILLS (chills). At the time of the report, CHILLS (chills) outcome was unknown.            Concomitant product use was not provided by the reporter.  Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-054725 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-054725:1st dose
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Dizziness, Nausea, Vomiting
Clinical narrative: Dizziness; Light headedness; Nausea; Vomiting; This spontaneous case was reported by a physician and describes the occurrence of DIZZINESS (Dizziness), DIZZINESS (Light headedness), NAUSEA (Nausea) and VOMITING (Vomiting) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high. Concomitant products included AMLODIPINE, LOSARTAN and DOXAZOSIN for Blood pressure high.    On 15-Mar-2021 at 8:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021 at 9:00 AM, the patient experienced DIZZINESS (Dizziness), DIZZINESS (Light headedness), NAUSEA (Nausea) and VOMITING (Vomiting). On 22-Mar-2021, NAUSEA (Nausea) and VOMITING (Vomiting) had resolved. At the time of the report, DIZZINESS (Dizziness) and DIZZINESS (Light headedness) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: unknown (Inconclusive) unknown.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient took treatment for vomiting and dizziness in emergency room.  Patient went to emergency room on 15-mar-2021 and discharged on the same day.   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Reporter address was updated, patient demographics added, patient's medical history added, lab data added, vaccine onset time added, concomitant products were added, event onset time added, emergency room visit date  added, event outcome for all events  were updated from unknown to recovered with stop dates,  unspecified treatment medication was mentioned.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity, Pyrexia
Clinical narrative: SORENESS ALONG THE BCK OF BUTTOCKS AND BACK OF LEG; FEVER OF 102.5; FATIGUE; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (SORENESS ALONG THE BCK OF BUTTOCKS AND BACK OF LEG), PYREXIA (FEVER OF 102.5) and FATIGUE (FATIGUE) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (SORENESS ALONG THE BCK OF BUTTOCKS AND BACK OF LEG), PYREXIA (FEVER OF 102.5) and FATIGUE (FATIGUE). At the time of the report, PAIN IN EXTREMITY (SORENESS ALONG THE BCK OF BUTTOCKS AND BACK OF LEG), PYREXIA (FEVER OF 102.5) and FATIGUE (FATIGUE) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       patient have fever 102.5  Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain
Clinical narrative: body ache; chills; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body ache), CHILLS (chills) and HEADACHE (headache) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced PAIN (body ache), CHILLS (chills) and HEADACHE (headache). The patient was treated with ACETYLSALICYLIC ACID (ASPRIN) for Adverse event, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN (body ache), CHILLS (chills) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: Fever - Temperature of 100.6F; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever - Temperature of 100.6F) and VOMITING (Vomiting) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced PYREXIA (Fever - Temperature of 100.6F) and VOMITING (Vomiting). The patient was treated with IBUPROFEN for Fever and Vomiting, at a dose of 1 dosage form. At the time of the report, PYREXIA (Fever - Temperature of 100.6F) and VOMITING (Vomiting) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Mar-2021, Pyrexia: 100.6 (High) high.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication provided. Treatment information included Ibuprofen.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site reaction, Injection site swelling
Clinical narrative: Hardness at injection site; Swelling at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE REACTION (Hardness at injection site) and INJECTION SITE SWELLING (Swelling at injection site) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 3001176) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced INJECTION SITE REACTION (Hardness at injection site) and INJECTION SITE SWELLING (Swelling at injection site). At the time of the report, INJECTION SITE REACTION (Hardness at injection site) and INJECTION SITE SWELLING (Swelling at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Warmth at the site of injection in left arm 1 week after the vaccination; Swelling at the site of injection in left arm 1 week after the vaccination; tching at the site of injection in left arm 1 week after the vaccination; Redness at the site of injection in left arm 1 week after the vaccination; Pain at the site of injection in left arm 1 week after the vaccination; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warmth at the site of injection in left arm 1 week after the vaccination), VACCINATION SITE SWELLING (Swelling at the site of injection in left arm 1 week after the vaccination), VACCINATION SITE PRURITUS (tching at the site of injection in left arm 1 week after the vaccination), VACCINATION SITE ERYTHEMA (Redness at the site of injection in left arm 1 week after the vaccination) and VACCINATION SITE PAIN (Pain at the site of injection in left arm 1 week after the vaccination) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Warmth at the site of injection in left arm 1 week after the vaccination), VACCINATION SITE SWELLING (Swelling at the site of injection in left arm 1 week after the vaccination), VACCINATION SITE PRURITUS (tching at the site of injection in left arm 1 week after the vaccination), VACCINATION SITE ERYTHEMA (Redness at the site of injection in left arm 1 week after the vaccination) and VACCINATION SITE PAIN (Pain at the site of injection in left arm 1 week after the vaccination). At the time of the report, VACCINATION SITE WARMTH (Warmth at the site of injection in left arm 1 week after the vaccination), VACCINATION SITE SWELLING (Swelling at the site of injection in left arm 1 week after the vaccination), VACCINATION SITE PRURITUS (tching at the site of injection in left arm 1 week after the vaccination), VACCINATION SITE ERYTHEMA (Redness at the site of injection in left arm 1 week after the vaccination) and VACCINATION SITE PAIN (Pain at the site of injection in left arm 1 week after the vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.   No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: TCR follow up. Pt declined to provide email and said is better.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Blood thyroid stimulating hormone, Pain in extremity
Clinical narrative: little pain in his left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (little pain in his left arm) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     Concomitant products included METFORMIN and VITAMINS NOS for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced PAIN IN EXTREMITY (little pain in his left arm). At the time of the report, PAIN IN EXTREMITY (little pain in his left arm) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Mar-2021, Blood thyroid stimulating hormone: high (High) high.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Lab data: TPO Ab level were very high. Concomitant product: Thyroid medication.  Treatment information was not provided.   This case was linked to MOD-2021-054740, MOD-2021-054740 (Patient Link).
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test
Clinical narrative: Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced PYREXIA. On 28-Feb-2021, PYREXIA had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In October 2020, SARS-CoV-2 test: positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient had a fever of 101.4 degree F. No concomitant medication were reported. No treatment information was provided.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Cerebral disorder, Inflammation, Myalgia, Sensitive skin
Clinical narrative: Brain fog; Inflammation throughout the body; Joint pain; muscle aches; Sensitive skin; This spontaneous case was reported by a consumer and describes the occurrence of CEREBRAL DISORDER (Brain fog), SENSITIVE SKIN (Sensitive skin), INFLAMMATION (Inflammation throughout the body), ARTHRALGIA (Joint pain) and MYALGIA (Muscle aches) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.  No Medical History information was reported.  On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced CEREBRAL DISORDER (Brain fog), SENSITIVE SKIN (Sensitive skin), INFLAMMATION (Inflammation throughout the body), ARTHRALGIA (Joint pain) and MYALGIA (Muscle aches). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, CEREBRAL DISORDER (Brain fog), SENSITIVE SKIN (Sensitive skin), INFLAMMATION (Inflammation throughout the body), ARTHRALGIA (Joint pain) and MYALGIA (Muscle aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Vertigo
Clinical narrative: Dizziness; Vertigo; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) and VERTIGO (Vertigo) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced DIZZINESS (Dizziness) and VERTIGO (Vertigo). At the time of the report, DIZZINESS (Dizziness) and VERTIGO (Vertigo) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was provided.   This case was linked to MOD-2021-054759 (Patient Link).
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Pain, Pyrexia, Vertigo
Clinical narrative: Dizziness; Vertigo; Body aches; Chills; Fever; Slight dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Slight dizziness), DIZZINESS (Dizziness), VERTIGO (Vertigo), PAIN (Body aches) and CHILLS (Chills) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On 13-Mar-2021, the patient experienced DIZZINESS (Slight dizziness), PAIN (Body aches), CHILLS (Chills) and PYREXIA (Fever). On 23-Mar-2021, the patient experienced DIZZINESS (Dizziness) and VERTIGO (Vertigo). At the time of the report, DIZZINESS (Slight dizziness), DIZZINESS (Dizziness), VERTIGO (Vertigo), PAIN (Body aches), CHILLS (Chills) and PYREXIA (Fever) outcome was unknown.            No concomitant medications were reported.  No treatment information was provided.   This case was linked to MOD-2021-054753 (E2B Linked Report). This case was linked to MOD-2021-054753 (Patient Link).; Sender's Comments:  MOD-2021-054753:patient link
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Vaccination site erythema
Clinical narrative: headache; Arm became red; This spontaneous case was reported by a pharmacist and describes the occurrence of HEADACHE (headache) and VACCINATION SITE ERYTHEMA (Arm became red) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     Concomitant products included CICLOSPORIN (RESTASIS) and BRIMONIDINE TARTRATE, TIMOLOL MALEATE (COMBIGAN) for an unknown indication.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced HEADACHE (headache). February 2021, the patient experienced VACCINATION SITE ERYTHEMA (Arm became red). At the time of the report, HEADACHE (headache) and VACCINATION SITE ERYTHEMA (Arm became red) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   It was reported that the patient also took an unspecified blood pressure medicine concomitantly. No treatment medications were reported.   This case was linked to MOD-2021-054774 (Patient Link).
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Gait disturbance, Paraesthesia
Clinical narrative: left leg has "fallen asleep from the buttock area and down his left leg"; when he walks it is not a natural motion, it's a forced; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (left leg has "fallen asleep from the buttock area and down his left leg") and GAIT DISTURBANCE (when he walks it is not a natural motion, it's a forced) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021 at 12:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced PARAESTHESIA (left leg has "fallen asleep from the buttock area and down his left leg") and GAIT DISTURBANCE (when he walks it is not a natural motion, it's a forced). At the time of the report, PARAESTHESIA (left leg has "fallen asleep from the buttock area and down his left leg") and GAIT DISTURBANCE (when he walks it is not a natural motion, it's a forced) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant drugs were reported. No treatment medications were reported.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Visual impairment
Clinical narrative: couldn't see well; This spontaneous case was reported by a consumer and describes the occurrence of VISUAL IMPAIRMENT (couldn't see well) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Mar-2021, the patient experienced VISUAL IMPAIRMENT (couldn't see well). At the time of the report, VISUAL IMPAIRMENT (couldn't see well) had resolved.            Concomitant medication was not provided by the reporter.   Patient reported rinsing his eye and washing his face in the morning  of 22Mar2021.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 03-Jul-2021: NNI received
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 062G20A and 031C20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included TRAMADOL, ESTRADIOL, PANTOPRAZOLE, LEVOCETIRIZINE, MONTELUKAST, POTASSIUM, HYDROCHLOROTHIAZIDE, TRIAMTERENE (TRIAMTERENE/HYDROCHLOROTHIAZIDE) and FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF) for an unknown indication.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD21-039239 (Patient Link).
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Sleep disorder, Somnolence
Clinical narrative: Feeling drowsy; Sleep is also affected; Feeling achy; Feeling tired; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Feeling drowsy), SLEEP DISORDER (Sleep is also affected), MYALGIA (Feeling achy) and FATIGUE (Feeling tired) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication.   On 19-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced SOMNOLENCE (Feeling drowsy), SLEEP DISORDER (Sleep is also affected), MYALGIA (Feeling achy) and FATIGUE (Feeling tired). At the time of the report, SOMNOLENCE (Feeling drowsy), SLEEP DISORDER (Sleep is also affected), MYALGIA (Feeling achy) and FATIGUE (Feeling tired) outcome was unknown.            It was reported that the patient was waking up at night and sleeping 5 to 6 hours per night. On 23-Mar-2021, the patient took a nap which lasted for an hour and it was really long. Action taken with mRNA-1273 in response to the event was not applicable.No treatment information was provided.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Tested positive for Covid; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for Covid) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 037K20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in July 2020. Concurrent medical conditions included Drug allergy (Ibuprofen), Allergy to antibiotic (Cipro), Drug allergy (Morphine), Drug allergy (Narcan) and Drug allergy (Vicodin).   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Mar-2021, the patient experienced COVID-19 (Tested positive for Covid). At the time of the report, COVID-19 (Tested positive for Covid) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In July 2020, SARS-CoV-2 test: positive (Positive) Positive. On 22-Mar-2021, SARS-CoV-2 test: positive (Positive) Positive.         Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medications were reported. Treatment information was unknown.   Reporter did not allow further contact
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Feeling hot, Pain, Pruritus
Clinical narrative: Hot to the touch; Itch; Body aches; rashes on hands and face; Fever; Joint pain; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Hot to the touch), PRURITUS (Itch), PAIN (Body aches), RASH (rashes on hands and face) and PYREXIA (Fever) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Fibromyalgia. Concomitant products included MILNACIPRAN HYDROCHLORIDE (SAVELLA), DICLOFENAC POTASSIUM (VOLTAREN ACTI) and TRAZODONE for Fibromyalgia.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced FEELING HOT (Hot to the touch), PRURITUS (Itch), PAIN (Body aches), RASH (rashes on hands and face), PYREXIA (Fever), ARTHRALGIA (Joint pain) and FATIGUE (Fatigue). At the time of the report, FEELING HOT (Hot to the touch), PRURITUS (Itch), PAIN (Body aches), RASH (rashes on hands and face), PYREXIA (Fever), ARTHRALGIA (Joint pain) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment details pertained to the events were provided.